The Food and Drug Administration (FDA) conducted an inspection of Cardinal Health 414, LLC in Birmingham on March 16 related to drug quality assurance, as reported on the FDA’s website.
The final inspection report showed that Cardinal Health 414, LLC did not need to implement any corrective actions regarding its management practices.
The FDA regularly inspects facilities throughout the United States to confirm workplace and product compliance with laws and regulations designed to protect public health. The outcomes of these inspections are shared publicly.
The agency’s website reports that the FDA oversees the safety and quality of human and animal drugs, biological products, medical supplies and tobacco goods.
Information for this article was sourced from the U.S. Food and Drug Administration. You can access the original data here.
